Viewing Study NCT00522834


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-30 @ 9:34 PM
Study NCT ID: NCT00522834
Status: TERMINATED
Last Update Posted: 2014-03-04
First Post: 2007-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Sponsor: Synta Pharmaceuticals Corp.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None melanoma View
None oncology View
None Stage IV Metastatic Melanoma View